GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lattice Biologics Ltd (TSXV:LBL.H) » Definitions » Cyclically Adjusted PB Ratio

Lattice Biologics (TSXV:LBL.H) Cyclically Adjusted PB Ratio : (As of Jun. 11, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Lattice Biologics Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Lattice Biologics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Lattice Biologics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lattice Biologics Cyclically Adjusted PB Ratio Chart

Lattice Biologics Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Sep16 Sep17 Sep18 Sep19 Sep20
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Lattice Biologics Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lattice Biologics's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Lattice Biologics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lattice Biologics's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lattice Biologics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lattice Biologics's Cyclically Adjusted PB Ratio falls into.



Lattice Biologics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Lattice Biologics's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2021 is calculated as:

For example, Lattice Biologics's adjusted Book Value per Share data for the three months ended in Jun. 2021 was:

Adj_Book=Book Value per Share/CPI of Jun. 2021 (Change)*Current CPI (Jun. 2021)
=0.001/114.6314*114.6314
=0.001

Current CPI (Jun. 2021) = 114.6314.

Lattice Biologics Quarterly Data

Book Value per Share CPI Adj_Book
201109 7.294 95.727 8.734
201112 0.134 95.213 0.161
201203 0.186 96.783 0.220
201206 0.079 96.819 0.094
201209 0.019 97.633 0.022
201212 -0.028 96.871 -0.033
201303 -0.083 98.209 -0.097
201306 -0.131 98.518 -0.152
201309 -0.158 98.790 -0.183
201312 -0.191 98.326 -0.223
201403 -0.203 99.695 -0.233
201406 -0.221 100.560 -0.252
201409 -0.233 100.428 -0.266
201412 -0.272 99.070 -0.315
201503 -0.295 99.621 -0.339
201506 -0.296 100.684 -0.337
201509 -0.365 100.392 -0.417
201512 -0.341 99.792 -0.392
201603 -0.132 100.470 -0.151
201606 -0.154 101.688 -0.174
201609 -0.122 101.861 -0.137
201612 -0.111 101.863 -0.125
201703 -0.118 102.862 -0.132
201706 -0.049 103.349 -0.054
201709 -0.056 104.136 -0.062
201712 -0.059 104.011 -0.065
201803 -0.063 105.290 -0.069
201806 -0.072 106.317 -0.078
201809 -0.074 106.507 -0.080
201812 -0.078 105.998 -0.084
201903 -0.077 107.251 -0.082
201906 -0.080 108.070 -0.085
201909 -0.089 108.329 -0.094
201912 -0.090 108.420 -0.095
202003 -0.108 108.902 -0.114
202006 -0.084 108.767 -0.089
202009 -0.066 109.815 -0.069
202012 -0.067 109.897 -0.070
202103 -0.016 111.754 -0.016
202106 0.001 114.631 0.001

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Lattice Biologics  (TSXV:LBL.H) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Lattice Biologics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Lattice Biologics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lattice Biologics (TSXV:LBL.H) Business Description

Traded in Other Exchanges
N/A
Address
512 East Madison Avenue, Suite A1, Belgrade, MT, USA, 59714
Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The products of the company include ADM dermis, DBM Putty, Bone scaffold, and Others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.

Lattice Biologics (TSXV:LBL.H) Headlines

No Headlines